{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:24Z","timestamp":1792511964964,"version":"4.5.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Reperfusion therapies are the mainstay of acute ischemic stroke (AIS) treatments and overall improve functional outcome. Among the established complications of intravenous (IV) tissue-type plasminogen activator (tPA), intracranial hemorrhage (ICH) is by far the most feared and has been extensively described by seminal works over the last two decades. Indeed, IV tPA is associated with increased odds of any ICH and symptomatic ICH responsible for increased mortality rate during the first week after an AIS. Despite these results, IV tPA has been found beneficial in several pioneering randomized trials and improves functional outcome at 3 months. Endovascular therapy (EVT) combined with IV tPA for AIS patients consecutive to an anterior circulation large-vessel occlusion does not increase ICH occurrence. Of note, EVT following IV tPA leads to significantly higher rates of early reperfusion than with IV tPA alone, with no difference in ICH, which challenges the paradigm of reperfusion as a major prognostic factor for ICH complications. However, several blood biomarkers (glycemia, platelet and neutrophil count), clinical factors (age, AIS severity, blood pressure management, diabetes mellitus), and neuroradiological factors (cerebral microbleeds, infarct size) have been identified as risk factors for ICH after reperfusion therapy. In the years to come, the ultimate goal will be to further improve either reperfusion rates and functional outcome, while reducing hemorrhagic complications. To this end, various approaches being investigated are discussed in this review, such as blood-pressure control after reperfusion or the use of new antiplatelet agents as an adjunct to IV tPA and exhibit reduced hemorrhagic potential during the early phase of AIS.<\/jats:p>","DOI":"10.3389\/fneur.2020.599908","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T06:59:22Z","timestamp":1607669962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Benjamin","family":"Ma\u00efer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Desilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Mazighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019. Update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"B2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/neurintsurg-2018-014569","article-title":"European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke","volume":"11","author":"Turc","year":"2019","journal-title":"J Neurointerv Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00002826-199008000-00001","article-title":"Thrombolytic agents in the treatment of stroke","volume":"13","author":"Pessin","year":"1990","journal-title":"Clin Neuropharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/01.STR.0000196942.84707.71","article-title":"Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke","volume":"37","author":"Trouillas","year":"2006","journal-title":"Stroke."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1161\/STROKEAHA.118.024512","article-title":"Predictors of parenchymal hematoma after mechanical thrombectomy: a multicenter study","volume":"50","author":"Boisseau","year":"2019","journal-title":"Stroke."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","article-title":"Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study","volume":"39","author":"Paciaroni","year":"2008","journal-title":"Stroke."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1055\/s-0038-1652446","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"J Biol Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0002-9149(98)00018-6","article-title":"Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction","volume":"81","author":"Stangl","year":"1998","journal-title":"Am J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/0735-1097(92)90297-Z","article-title":"Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction","volume":"19","author":"Tanswell","year":"1992","journal-title":"J Am Coll Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0735-1097(87)80188-2","article-title":"Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator","volume":"10","author":"Mueller","year":"1987","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1212\/WNL.0b013e3182897015","article-title":"Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis","volume":"80","author":"Matosevic","year":"2013","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1161\/01.STR.28.5.957","article-title":"Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study","volume":"28","author":"Larrue","year":"1997","journal-title":"Stroke."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.274.13.1017","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/01.STR.32.6.1330","article-title":"Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?","volume":"32","author":"Berger","year":"2001","journal-title":"Stroke."},{"key":"B20","first-page":"1115","article-title":"Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery","volume":"12","author":"Bozzao","year":"1991","journal-title":"Am J Neuroradiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1212\/WNL.46.2.341","article-title":"Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome","volume":"46","author":"Toni","year":"1996","journal-title":"Neurology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.STR.17.2.179","article-title":"Hemorrhagic cerebral infarction\u2013a prospective study","volume":"17","author":"Hornig","year":"1986","journal-title":"Stroke."},{"key":"B23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000117012","article-title":"Hemorrhagic infarcts","volume":"34","author":"Moulin","year":"1994","journal-title":"Eur Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/01.STR.25.2.291","article-title":"Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke","volume":"25","author":"Levy","year":"1994","journal-title":"Stroke."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy","volume":"46","author":"von Kummer","year":"2015","journal-title":"Stroke."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/neurintsurg-2018-013848","article-title":"Prognosis of asymptomatic intracranial hemorrhage after endovascular treatment","volume":"11","author":"Hao","year":"2019","journal-title":"J Neurointerv Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.006","article-title":"Asymptomatic intracerebral hemorrhage may worsen clinical outcomes in acute ischemic stroke patients undergoing thrombectomy","volume":"28","author":"Jiang","year":"2019","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"The NINDS t-PA Stroke Study Group","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke."},{"key":"B31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0140-6736(19)31053-0","article-title":"Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data","volume":"394","author":"Campbell","year":"2019","journal-title":"Lancet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"Sandercock","year":"2012","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","article-title":"Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials","volume":"363","author":"Hacke","year":"2004","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","article-title":"low-dose versus standard-dose intravenous alteplase in acute ischemic stroke","volume":"374","author":"Anderson","year":"2016","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-guided thrombolysis for stroke with unknown time of onset","volume":"379","author":"Thomalla","year":"2018","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke","volume":"380","author":"Ma","year":"2019","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(16)30076-X","article-title":"Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis","volume":"15","author":"Whiteley","year":"2016","journal-title":"Lancet Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1161\/01.STR.32.2.438","article-title":"Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)","volume":"32","author":"Larrue","year":"2001","journal-title":"Stroke."},{"key":"B41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1161\/STROKEAHA.114.006268","article-title":"Early deterioration after thrombolysis plus aspirin in acute stroke: a post hoc analysis of the antiplatelet therapy in combination with recombinant t-PA thrombolysis in ischemic stroke trial","volume":"45","author":"Zinkstok","year":"2014","journal-title":"Stroke."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1161\/STROKEAHA.111.644815","article-title":"Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score","volume":"43","author":"Mazya","year":"2012","journal-title":"Stroke."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke."},{"key":"B45","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/01.STR.31.2.370","article-title":"Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience","volume":"31","author":"Tanne","year":"2000","journal-title":"Stroke."},{"key":"B46","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/jnnp.2005.086595","article-title":"Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian alteplase for stroke effectiveness study","volume":"77","author":"Sylaja","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","first-page":"c6046","DOI":"10.1136\/bmj.c6046","article-title":"Thrombolysis in very elderly people: controlled comparison of SITS international stroke thrombolysis registry and virtual international stroke trials archive","volume":"341","author":"Mishra","year":"2010","journal-title":"BMJ."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/STROKEAHA.110.581884","article-title":"Intravenous alteplase for stroke in those older than 80 years old","volume":"41","author":"Ford","year":"2010","journal-title":"Stroke."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1161\/01.CIR.0000012747.53592.6A","article-title":"Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey","volume":"105","author":"Tanne","year":"2002","journal-title":"Circulation."},{"key":"B50","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/ageing\/afl104","article-title":"Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age\u2013a systematic review across cohort studies","volume":"35","author":"Engelter","year":"2006","journal-title":"Age Ageing."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000103110","article-title":"Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors","volume":"24","author":"Lansberg","year":"2007","journal-title":"Cerebrovasc Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1212\/WNL.0000000000002199","article-title":"IV thrombolysis in very severe and severe ischemic stroke: results from the SITS-ISTR registry","volume":"85","author":"Mazya","year":"2015","journal-title":"Neurology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1161\/STROKEAHA.119.027071","article-title":"Safety and outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke: results from the safe implementation of treatments in stroke registry and meta-analysis","volume":"51","author":"Keselman","year":"2020","journal-title":"Stroke."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6843895","DOI":"10.1155\/2019\/6843895","article-title":"Hypertension and its impact on stroke recovery: from a vascular to a parenchymal overview","volume":"2019","author":"Maier","year":"2019","journal-title":"Neural Plast."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1161\/01.STR.0000014509.11540.66","article-title":"Blood pressure and clinical outcomes in the International Stroke Trial","volume":"33","author":"Leonardi-Bee","year":"2002","journal-title":"Stroke."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1161\/STROKEAHA.109.564096","article-title":"Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage","volume":"40","author":"Tsivgoulis","year":"2009","journal-title":"Stroke."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1161\/STROKEAHA.109.548602","article-title":"Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR)","volume":"40","author":"Ahmed","year":"2009","journal-title":"Stroke."},{"key":"B58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1161\/STROKEAHA.109.563767","article-title":"Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation","volume":"41","author":"Butcher","year":"2010","journal-title":"Stroke."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1161\/STROKEAHA.115.010319","article-title":"Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third International Stroke Trial of thrombolytic treatment for acute ischemic stroke","volume":"46","author":"Berge","year":"2015","journal-title":"Stroke."},{"key":"B60","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1212\/01.wnl.0000318294.36223.69","article-title":"Prognostic significance of blood pressure variability after thrombolysis in acute stroke","volume":"71","author":"Delgado-Mederos","year":"2008","journal-title":"Neurology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/STROKEAHA.117.016876","article-title":"Reciprocal interaction of 24-hour blood pressure variability and systolic blood pressure on outcome in stroke thrombolysis","volume":"48","author":"Kellert","year":"2017","journal-title":"Stroke."},{"key":"B62","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0140-6736(19)30038-8","article-title":"Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial","volume":"393","author":"Anderson","year":"2019","journal-title":"Lancet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/STROKEAHA.111.000813","article-title":"Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review","volume":"44","author":"Desilles","year":"2013","journal-title":"Stroke."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1161\/STROKEAHA.117.017080","article-title":"Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation","volume":"48","author":"Desilles","year":"2017","journal-title":"Stroke."},{"key":"B65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjmed.2010.07.028","article-title":"Race, bleeding, and outcomes in STEMI patients treated with fibrinolytic therapy","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/STROKEAHA.115.008781","article-title":"Acute reperfusion therapy and stroke care in Asia after successful endovascular trials","volume":"46","author":"Toyoda","year":"2015","journal-title":"Stroke."},{"key":"B67","doi-asserted-by":"publisher","first-page":"104474","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104474","article-title":"RAcial Disparities in Ich after IV-tPA and Neurointerventional Treatment (RADIANT)","volume":"29","author":"Chiang","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/STROKEAHA.114.005019","article-title":"Race\/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy","volume":"45","author":"Mehta","year":"2014","journal-title":"Stroke."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/01.STR.0000023577.65990.4E","article-title":"Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume","volume":"33","author":"Selim","year":"2002","journal-title":"Stroke."},{"key":"B70","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archneur.58.4.587","article-title":"Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging","volume":"58","author":"Tong","year":"2001","journal-title":"Arch Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1161\/STROKEAHA.106.480475","article-title":"Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke","volume":"38","author":"Lansberg","year":"2007","journal-title":"Stroke."},{"key":"B72","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamaneurol.2016.0292","article-title":"Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis","volume":"73","author":"Tsivgoulis","year":"2016","journal-title":"JAMA Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1161\/STROKEAHA.116.012992","article-title":"Microbleeds, cerebral hemorrhage, and functional outcome after stroke thrombolysis","volume":"48","author":"Charidimou","year":"2017","journal-title":"Stroke."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1212\/WNL.0000000000002029","article-title":"Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes","volume":"85","author":"Maestrini","year":"2015","journal-title":"Neurology."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1212\/WNL.0000000000007859","article-title":"Neutrophil count predicts poor outcome despite recanalization after endovascular therapy","volume":"93","author":"Boisseau","year":"2019","journal-title":"Neurology."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e690","DOI":"10.1212\/WNL.0000000000004982","article-title":"Intravenous thrombolysis and platelet count","volume":"90","author":"Gensicke","year":"2018","journal-title":"Neurology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000504214","article-title":"Safety of intravenous thrombolysis for acute ischemic stroke in patients with thrombocytopenia","volume":"48","author":"Yang","year":"2019","journal-title":"Cerebrovasc Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/01.STR.0000126040.99024.cf","article-title":"Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases","volume":"35","author":"Trouillas","year":"2004","journal-title":"Stroke."},{"key":"B79","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1474-4422(18)30242-4","article-title":"Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data","volume":"17","author":"Roman","year":"2018","journal-title":"Lancet Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1161\/CIRCULATIONAHA.112.000311","article-title":"Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis","volume":"127","author":"Mazighi","year":"2013","journal-title":"Circulation."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","article-title":"Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis","volume":"316","author":"Saver","year":"2016","journal-title":"JAMA."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/STROKEAHA.118.024255","article-title":"Clinical and imaging markers associated with hemorrhagic transformation in patients with acute ischemic stroke","volume":"50","author":"Kranendonk","year":"2019","journal-title":"Stroke."},{"key":"B83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/neurintsurg-2013-010743","article-title":"Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients","volume":"7","author":"Nogueira","year":"2015","journal-title":"J Neurointerv Surg."},{"key":"B84","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2017.9644","article-title":"Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial","volume":"318","author":"Lapergue","year":"2017","journal-title":"JAMA."},{"key":"B85","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(19)30297-1","article-title":"Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial","volume":"393","author":"Turk","year":"2019","journal-title":"Lancet."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jamaneurol.2016.2773","article-title":"Endovascular therapy for acute ischemic stroke with occlusion of the middle cerebral artery M2 segment","volume":"73","author":"Sarraj","year":"2016","journal-title":"JAMA Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/neurintsurg-2014-011232","article-title":"M2 occlusions as targets for endovascular therapy: comprehensive analysis of diffusion\/perfusion MRI, angiography, and clinical outcomes","volume":"7","author":"Sheth","year":"2015","journal-title":"J Neurointerv Surg."},{"key":"B88","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamaneurol.2016.5823","article-title":"Two paradigms for endovascular thrombectomy after intravenous thrombolysis for acute ischemic stroke","volume":"74","author":"Gerschenfeld","year":"2017","journal-title":"JAMA Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/neurintsurg-2016-012824","article-title":"Hospital transfer associated with increased mortality after endovascular revascularization for acute ischemic stroke","volume":"9","author":"Rinaldo","year":"2017","journal-title":"J Neurointerv Surg."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/STROKEAHA.119.026769","article-title":"Effect of steady and dynamic blood pressure parameters during thrombectomy according to the collateral status","volume":"51","author":"Ma\u00efer","year":"2020","journal-title":"Stroke"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/STROKEAHA.119.024915","article-title":"Association of blood pressure during thrombectomy for acute ischemic stroke with functional outcome a systematic review","volume":"50","author":"Ma\u00efer","year":"2019","journal-title":"Stroke."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e009378","DOI":"10.1161\/JAHA.118.009378","article-title":"Prognostic significance of pulse pressure variability during mechanical thrombectomy in acute ischemic stroke patients","volume":"7","author":"Maier","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e006484","DOI":"10.1161\/JAHA.117.004193","article-title":"Mortality and disability according to baseline blood pressure in acute ischemic stroke patients treated by thrombectomy: a collaborative pooled analysis","volume":"6","author":"Maier","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1161\/STROKEAHA.117.017996","article-title":"Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands)","volume":"48","author":"Mulder","year":"2017","journal-title":"Stroke."},{"key":"B95","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/neurintsurg-2019-015247","article-title":"A 10% blood pressure drop from baseline during the procedure is strongly associated with worse neurological outcomes after thrombectomy for stroke","volume":"12","author":"Valent","year":"2019","journal-title":"J Neurointerv Surg."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/STROKEAHA.118.024286","article-title":"Decreases in blood pressure during thrombectomy are associated with larger infarct volumes and worse functional outcome","volume":"50","author":"Petersen","year":"2019","journal-title":"Stroke."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/STROKEAHA.117.019709","article-title":"Association of blood pressure with short- and long-term functional outcome after stroke thrombectomy: post hoc analysis of the SIESTA trial","volume":"49","author":"Sch\u00f6nenberger","year":"2018","journal-title":"Stroke."},{"key":"B98","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jamaneurol.2019.4838","article-title":"Blood pressure thresholds and neurologic outcomes after endovascular therapy for acute ischemic stroke: an analysis of individual patient data from 3 randomized clinical trials","volume":"77","author":"Rasmussen","year":"2020","journal-title":"JAMA Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.25434","article-title":"Blood pressure variability and hemorrhagic transformation in patients with successful recanalization after endovascular recanalization therapy: a retrospective observational study","volume":"85","author":"Kim","year":"2019","journal-title":"Ann Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1161\/str.50.suppl_1.153","article-title":"Blood pressure and outcome after mechanical thrombectomy with successful revascularization: a multicenter study","volume":"50","author":"Anadani","year":"2019","journal-title":"Stroke."},{"key":"B101","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/STROKEAHA.119.026914","article-title":"Blood pressure after endovascular thrombectomy: modeling for outcomes based on recanalization status","volume":"51","author":"Matusevicius","year":"2020","journal-title":"Stroke"},{"key":"B102","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fneur.2020.00480","article-title":"Blood pressure target in acute stroke to reduce hemorrhage after endovascular therapy: the randomized BP TARGET Study protocol","volume":"11","author":"Mazighi","year":"2020","journal-title":"Front Neurol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/jcph.1616","article-title":"Population pharmacokinetic\/pharmacodynamic modeling of glenzocimab (ACT017) a glycoprotein VI inhibitor of collagen-induced platelet aggregation","volume":"60","author":"Renaud","year":"2020","journal-title":"J Clin Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ana.23546","article-title":"Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score","volume":"71","author":"Strbian","year":"2012","journal-title":"Ann Neurol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1161\/STROKEAHA.120.030173","article-title":"Symptomatic intracranial hemorrhage after mechanical thrombectomy in Chinese ischemic stroke patients: the ASIAN score","volume":"51","author":"Zhang","year":"2020","journal-title":"Stroke."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.599908\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T06:59:24Z","timestamp":1607669964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.599908\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":105,"alternative-id":["10.3389\/fneur.2020.599908"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.599908","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,11]]},"article-number":"599908"}}